Insider Transactions in Q1 2021 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.69%
|
$460,000
$46.73 P/Share
|
|
Mar 29
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.56%
|
$120,000
$12.15 P/Share
|
|
Mar 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.71%
|
$572,000
$52.96 P/Share
|
|
Mar 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+7.16%
|
$11,000
$1.6 P/Share
|
|
Mar 02
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,651
-0.61%
|
$92,456
$56.62 P/Share
|
|
Mar 01
2021
|
Erica J. Rogers President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-1.27%
|
$94,752
$56.75 P/Share
|
|
Mar 01
2021
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+14.0%
|
-
|
|
Mar 01
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
893
-0.5%
|
$50,008
$56.86 P/Share
|
|
Mar 01
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+5.98%
|
-
|
|
Mar 01
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-0.26%
|
$19,380
$57.12 P/Share
|
|
Mar 01
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
4,300
+3.15%
|
-
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
508
-1.57%
|
$28,448
$56.95 P/Share
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+26.65%
|
-
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$418,432
$56.49 P/Share
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Feb 26
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.55%
|
$51,352
$56.63 P/Share
|
|
Feb 26
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,676
+1.57%
|
-
|
|
Feb 26
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
1,047
+0.78%
|
-
|
|
Feb 26
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-0.27%
|
$19,600
$56.7 P/Share
|
|
Feb 26
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,828
+5.34%
|
-
|
|
Feb 26
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-1.68%
|
$29,232
$56.59 P/Share
|
|
Feb 24
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.96%
|
$530,000
$53.64 P/Share
|
|
Feb 24
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.89%
|
$80,000
$8.38 P/Share
|
|
Feb 17
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.73%
|
$10,000
$1.6 P/Share
|
|
Feb 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$649,000
$59.55 P/Share
|
|
Feb 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.6 P/Share
|
|
Feb 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$403,488
$54.12 P/Share
|
|
Feb 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Jan 27
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-6.08%
|
$540,000
$54.86 P/Share
|
|
Jan 27
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.73%
|
$40,000
$4.73 P/Share
|
|
Jan 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$649,000
$59.66 P/Share
|
|
Jan 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.6 P/Share
|
|
Jan 04
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$440,848
$59.67 P/Share
|
|
Jan 04
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|